FDA NDC Directory · JSON-LD · Markdown

Terconazole

NDC 0713-0552 · HUMAN PRESCRIPTION DRUG · SUPPOSITORY

Labeler / ManufacturerCosette Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA077553
Dosage form / routeSUPPOSITORY · VAGINAL
Active ingredientsTERCONAZOLE (80 mg/1)
Marketing started20150925
Package count1

External sources

Source: openFDA. Public-domain (CC0).